Abstract:Objective In association with innate and adaptive immunity, the microbiota controls the colonisation resistance against intestinal pathogens. Caspase recruitment domain 9 ( CARD9 ), a key innate immunity gene, is required to shape a normal gut microbiota. Card9 –/– mice are more susceptible to the enteric mouse pathogen Citrobacter rodentium that mimics human infections with enteropathogenic and enterohaemorrhagic Escherichia coli . Here, we examined how CARD9 controls C. rodentium infection susceptibility through microbiota-dependent and microbiota-independent mechanisms. Design C. rodentium infection was assessed in conventional and germ-free (GF) wild-type (WT) and Card9 –/– mice. To explore the impact of Card9 –/– microbiota in infection susceptibility, GF WT mice were colonised with WT (WT→GF) or Card9 –/– ( Card9 –/– →GF) microbiota before C. rodentium infection. Microbiota composition was determined by 16S rDNA gene sequencing. Inflammation severity was determined by histology score and lipocalin level. Microbiota–host immune system interactions were assessed by quantitative PCR analysis. Results CARD9 controls pathogen virulence in a microbiota-independent manner by supporting a specific humoral response. Higher susceptibility to C. rodentium -induced colitis was observed in Card9 –/– →GF mice. The microbiota of Card9 –/– mice failed to outcompete the monosaccharide-consuming C. rodentium , worsening the infection severity. A polysaccharide-enriched diet counteracted the ecological advantage of C. rodentium and the defective pathogen-specific antibody response in Card9 –/– mice. Conclusions CARD9 modulates the susceptibility to intestinal infection by controlling the pathogen virulence in a microbiota-dependent and microbiota-independent manner. Genetic susceptibility to intestinal pathogens can be overridden by diet intervention that restores humoural immunity and a competing microbiota.

The roles of CARD9 in immune responses against intracellular bacterial infection

The Roles of CARD9 in Immune Responses Against Intracellular Bacterial Infection (B170)

The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens

Role of CARD9 in Cell- and Organ-Specific Immune Responses in Various Infections

CARD9 Signaling, Inflammation, and Diseases

CARD9 Regulation and Its Role in Cardiovascular Diseases

The adaptor protein CARD9, from fungal immunity to tumorigenesis

The adaptor molecule CARD9 is essential for tuberculosis control

The Role of CARD9 Deficiency in Neutrophils

CARD9 in host immunity to fungal, bacterial, viral, and parasitic infections: An update

Human CARD9: A Critical Molecule of Fungal Immune Surveillance

Differential Use of CARD9 by Dectin-1 in Macrophages and Dendritic Cells1

Card9 Facilitates Microbe-Elicited Production of Reactive Oxygen Species by Regulating the Lygdi-Rac1 Complex

Differential Use of Card9 by Dectin-1 in Macrophages and Dendritic Cells

Card9 Broadly Regulates Host Immunity against Experimental Pulmonary Cryptococcus neoformans 52D Infection

CARD9 negatively regulates NLRP3-induced IL-1β production on Salmonella infection of macrophages

Impairment of Th cell response in Card9 knockout mice with cutaneous mucormycosis caused by Rhizopus arrhizus.

CARD9 Deficiencies Linked to Impaired Neutrophil Functions Against Phialophora verrucosa

Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulence

The Adaptor Protein CARD9 Protects Against Colon Cancer by Restricting Mycobiota-Mediated Expansion of Myeloid-Derived Suppressor Cells.

Card9 Protects Sepsis by Regulating Ripk2-mediated Activation of NLRP3 Inflammasome in Macrophages